Replies to post #240039 on Biotech Values

[DewDiligence]

ETTX majority shareholder makes takeunder offer @$1.80/sh:

https://www.globenewswire.com/news-release/2022/02/02/2378022/0/en/Entasis-Therapeutics-Receives-Acquisition-Proposal-from-Existing-Majority-Stockholder-Innoviva-Inc.html

I define a takeunder as any buyout where the buyout price is less than it would be in an arms-length transaction.